Home › Free Stock Grades › TWST
Twist Bioscience Corporation (TWST) Stock Grade
TWST · Healthcare
C
Market Cap
$11.2B
P/E Ratio
—
Revenue Growth (YoY)
+20.3%
Net Margin
-20.6%
Return on Equity
—
Dividend Yield
None
About Twist Bioscience Corporation's fundamentals
Twist Bioscience is a large-cap biotechnology company with a $11.2 billion market capitalization that generated 20.3% year-over-year revenue growth in its latest period. However, the company operates at a significant loss, with a net margin of -20.6%, and reported a net loss in its latest annual statement. The company does not currently pay dividends. Given the negative profitability metrics, traditional valuation ratios like P/E and return on equity are not applicable.